Court invalidates Otsuka's patent for injectable Abilify

Court invalidates Otsuka’s patent for injectable Abilify

Intellectual Property 2025-02-13 11:27 pm By Sam Matthews | Melbourne

Please login to bookmark

Generic drug maker Sun Pharma has succeeded in invalidating Otsuka Pharmaceutical’s patent for an injectable, controlled release form of the Japanese drug maker’s top-selling antipsychotic Abilify.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au